menu

Medical Industry Feature: Monoclonal Antibodies & Small Molecules: What Clinicians Need to Know

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Monoclonal Antibodies & Small Molecules: What Clinicians Need to Know

Monoclonal Antibodies & Small Molecules: What Clinicians Need to Know
RestartResume

What are the unique properties of monoclonal antibodies and small molecules, and how do these impact their respective clinical properties?

  • Overview

    While both small molecule drugs and monoclonal antibodies are considered targeted therapies, they each have unique characteristics that may influence how they’re used to treat diseases. That’s why Dr. Peter McAllister is here to explain how these two modalities differ in terms of structure, administration routes, and distribution.

                                                                                                                                                          USA-334-83595 

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 8/4/20